Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

COVID-19 patients exhibit differential disease severity after SARS-CoV-2 infection. It is currently unknown as to the correlation between the magnitude of neutralizing antibody (NAb) responses and the disease severity in COVID-19 patients. In a cohort of 59 recovered patients with disease severity i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiangyu, Pan, Zhiwei, Yue, Shuai, Yu, Fei, Zhang, Junsong, Yang, Yang, Li, Ren, Liu, Bingfeng, Yang, Xiaofan, Gao, Leiqiong, Li, Zhirong, Lin, Yao, Huang, Qizhao, Xu, Lifan, Tang, Jianfang, Hu, Li, Zhao, Jing, Liu, Pinghuang, Zhang, Guozhong, Chen, Yaokai, Deng, Kai, Ye, Lilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464057/
https://www.ncbi.nlm.nih.gov/pubmed/32879307
http://dx.doi.org/10.1038/s41392-020-00301-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464057/
https://www.ncbi.nlm.nih.gov/pubmed/32879307
http://dx.doi.org/10.1038/s41392-020-00301-9

Ejemplares similares